Stay updated on Nivolumab for Squamous Dysplasia Reversal Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, reflecting a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:21:16.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a Locations section highlighting Colorado as a study site; removed the old Colorado Locations entry and the HHS Vulnerability Disclosure, and updated the site revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:36:15.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Results-related updates were added to the study page, including a posting on 2025-12-12 and milestones for outcomes such as Endobronchial Histology and irAEs, plus links to the protocol document and revised enrollment/completion dates.
    Difference
    2%
    Check dated 2025-12-16T20:50:13.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added; previous revision v3.2.0 removed.
    Difference
    0.1%
    Check dated 2025-11-25T10:43:00.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The government funding and operating status notice was removed from the page. The study details content remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:53:18.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Minor formatting and textual tweaks were observed, with no changes to core study details, eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:58:17.000Z thumbnail image

Stay in the know with updates to Nivolumab for Squamous Dysplasia Reversal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.